CF101 2mg

DRUG2 trials

Sponsors

Can-Fite BioPharma

Conditions

Plaque Psoriasis

Phase 2

Safety and Efficacy Study of CF101 to Treat Psoriasis

CompletedNCT00428974

Can-Fite BioPharmaPlaque Psoriasis

Start: 2007-06-30End: 2009-09-30Updated: 2023-02-08

Phase 3

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

CompletedNCT03168256

Can-Fite BioPharmaPlaque Psoriasis

Start: 2018-09-15End: 2022-04-27Updated: 2022-06-28

Related Papers

Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (<scp>COMFORT</scp>‐1)

Journal of the European Academy of Dermatology and Venereology2024-01-2627 citations